Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Generated: June 24, 2018

DrugPatentWatch Database Preview

Chartwell Rx Company Profile

« Back to Dashboard

What is the competitive landscape for CHARTWELL RX, and what generic and branded alternatives to CHARTWELL RX drugs are available?

CHARTWELL RX has forty-seven approved drugs.

Summary for Chartwell Rx

US Patents:	0
Tradenames:	25
Ingredients:	22
NDAs:	47

Drugs and US Patents for Chartwell Rx

+ Get email alerts for changes to this table

This preview shows a limited data set. Subscribe for full access, or try a Free Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Chartwell Rx	PHENTERMINE HYDROCHLORIDE	phentermine hydrochloride	CAPSULE;ORAL	087915-001	Dec 22, 1983		DISCN	No	No		➤ Try a Free Trial				➤ Try a Free Trial
Chartwell Rx	PHENTERMINE HYDROCHLORIDE	phentermine hydrochloride	CAPSULE;ORAL	088611-001	Jun 4, 1984		DISCN	No	No		➤ Try a Free Trial				➤ Try a Free Trial
Chartwell Rx	FULVICIN P/G	griseofulvin, ultramicrocrystalline	TABLET;ORAL	061996-001	Approved Prior to Jan 1, 1982		DISCN	No	No		➤ Try a Free Trial				➤ Try a Free Trial
Chartwell Rx	CAM-METRAZINE	phendimetrazine tartrate	TABLET;ORAL	083922-001	Approved Prior to Jan 1, 1982		DISCN	No	No		➤ Try a Free Trial				➤ Try a Free Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Farmers Insurance

Chubb

Cipla

Johnson and Johnson

Julphar

Harvard Business School

Teva

US Department of Justice

Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.